On December 4, 2024, a high-level delegation from Japan's Haizhou Capital, including Kentaro Kodama (Elder), Kenhiro Akagi (President of Medical Aesthetics), and Ryuhei Yano (Senior Management), accompanied by Yang Yongbin, Executive Vice President of the Ningbo Intellectual Property Association, visited Zhejiang Tianyuan Biotechnology Co., Ltd., a subsidiary of Zhejiang Tianhao Holdings Co., Ltd., for cooperation and exchange. The purpose of this visit is to explore the potential for cooperation between the two sides in the field of biotechnology.

     Under the warm reception and leadership of Chairman Huang Bisheng, Group Executive Director Zhu Youwu, and Tianyuan Biotechnology General Manager Zhu Pengcheng, the Japanese delegation first visited the exhibition hall of Tianyuan Biotechnology. Through detailed explanations and presentations, the delegation gained a deep understanding of Tianyuan Biotechnology's business scope and research level. The delegation was deeply impressed by Tianyuan Biotechnology's innovative achievements and research and development capabilities in the field of biotechnology.

     Subsequently, the delegation visited Tianxuan Medical Laboratory to further understand the technical strength and advanced equipment of Tianyuan Biotechnology. The professional level and technical ability of the laboratory in the field of medical testing have been highly praised by the delegation. At the subsequent symposium, Mr. Zhu Pengcheng, the general manager, introduced the basic situation of the company, including its development history, main businesses, and market positioning.

     Subsequently, Chairman Huang Bisheng stated that the company will continue to adhere to the innovation driven development strategy, actively expand international cooperation, and strive to occupy a leading position in the global biotechnology field. Chairman Huang Bisheng's foresight and clear planning for the company's future development demonstrate the firm determination and confidence of Zhejiang Tianyuan Biotechnology Co., Ltd. on the path of globalization.

     Finally, both parties had preliminary discussions and exchanges on the stem cell (big health) project. The representative of Japan's Haizhou Capital Corporation expressed strong interest in the progress of Tianyuan Biotechnology in the field of stem cell research and expressed a willingness to further cooperate. Both parties had in-depth discussions on the possibility and direction of future cooperation, laying a solid foundation for future collaboration.

     The successful holding of this cooperation and exchange not only deepens the cooperation and exchange between China and Japan in the field of biotechnology, but also provides new opportunities for the international development of Zhejiang Tianyuan Biotechnology Co., Ltd. In the future, Zhejiang Tianyuan Biotechnology Co., Ltd. will continue to be committed to innovation and development in the field of biotechnology, and promote the globalization of the company's business.